Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Treasury Shares (2016 - 2025)

Enanta Pharmaceuticals filings provide 4 years of Treasury Shares readings, the most recent being $2000.0 for Q2 2015.

  • On a quarterly basis, Treasury Shares changed 0.0% to $2000.0 in Q2 2015 year-over-year; TTM through Jun 2015 was $2000.0, a 0.0% change, with the full-year FY2014 number at $2000.0, changed 0.0% from a year prior.
  • Treasury Shares hit $425000.0 in Q4 2025 for Enanta Pharmaceuticals, up from $93000.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $455000.0 in Q4 2023 to a low of $81000.0 in Q1 2023.
  • Median Treasury Shares over the past 5 years was $106000.0 (2021), compared with a mean of $170600.0.
  • The widest YoY moves for Treasury Shares: up 0.0% in 2013, down 0.0% in 2013.
  • Enanta Pharmaceuticals' Treasury Shares stood at $2000.0 in 2012, then changed by 0.0% to $2000.0 in 2013, then changed by 0.0% to $2000.0 in 2014, then changed by 0.0% to $2000.0 in 2015.
  • The last three reported values for Treasury Shares were $2000.0 (Q2 2015), $2000.0 (Q1 2015), and $2000.0 (Q4 2014) per Business Quant data.